Printer Friendly

CORRECTION TO ALLERGAN RESULTS.

 /C O R R E C T I O N -- ALLERGAN/
 In LA032, Allergan Results, moved earlier today, we are advised by


the company that four numbers under Allergan's Net Sales by Division, for Three Months ended March 31, 1991, are incorrect. The following is the correct table.
 ALLERGAN, INC.
 Net Sales by Division
 (Unaudited)
 Three Months
 in millions Ended March 31,
 1992 1991
 Specialty Pharmaceuticals
 Eye Care $ 86.0 $ 75.0
 Skin Care 5.9 5.6
 Total 91.9 80.6
 Surgical 26.1 23.5
 Optical 92.1 92.1
 TOTAL NET SALES $210.1 $196.2
 Domestic 48 pct 51 pct
 International 52 pct 49 pct
 -0- 4/21/92
 (AGN) CO: Allergan Inc. ST: California IN: MTC SU:


CH -- LA032X -- 0861 04/21/92 16:29 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 21, 1992
Words:132
Previous Article:BANCFLORIDA REPORTS SECOND QUARTER EARNINGS
Next Article:SFFED RELEASES MARCH CONSOLIDATED FINANCIAL HIGHLIGHTS


Related Articles
ALLERGAN REPORTS FIRST QUARTER OPERATING RESULTS.
ALLERGAN HONORED FOR BOTOX(TM) DEVELOPMENT BY NATIONAL ORGANIZATION FOR RARE DISORDERS
ALLERGAN SKIN CARE DIVISION WILL REPORT TO HAUGEN; W. RICHARD ULMER TO LEAVE ALLERGAN
Allergan and ACADIA Pharmaceuticals Establish a Research Collaboration
DCR Assigns Allergan A+/D-1 Ratings
Final Study Results Confirm AVAGE(R) Cream Faster and More Effective Than Renova(R) Cream; Compared with the Market Leader in Treating Signs of...
MultiVu Video Feed: Allergan Announces FDA Approval Of Juvederm(R) Gel Family of Products For the Treatment of Facial Wrinkles and Folds.
ALLERGAN ANNOUNCES FDA APPROVAL OF JUVEDERM(R) GEL FAMILY OF PRODUCTS FOR THE TREATMENT OF FACIAL WRINKLES AND FOLDS.
The JuvA[c]derm(R) ULTRA Range: Next-Generation Dermal Filler Treatment for Facial Wrinkles and Lines Now Available in the UK.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters